QSV Equity Investors LLC Has $1.52 Million Stake in Addus HomeCare Co. (NASDAQ:ADUS)

QSV Equity Investors LLC trimmed its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 23.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 11,402 shares of the company’s stock after selling 3,479 shares during the period. QSV Equity Investors LLC’s holdings in Addus HomeCare were worth $1,517,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in ADUS. Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. Millennium Management LLC grew its stake in shares of Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after acquiring an additional 254,705 shares in the last quarter. Wasatch Advisors LP grew its stake in shares of Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after acquiring an additional 110,010 shares in the last quarter. Ghisallo Capital Management LLC acquired a new position in shares of Addus HomeCare in the second quarter valued at about $11,611,000. Finally, Principal Financial Group Inc. grew its stake in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on ADUS. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Tuesday. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Stephens upped their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Trading Up 1.1 %

ADUS stock opened at $123.60 on Thursday. The stock has a market capitalization of $2.24 billion, a P/E ratio of 28.28, a price-to-earnings-growth ratio of 2.15 and a beta of 1.01. Addus HomeCare Co. has a 12 month low of $85.94 and a 12 month high of $136.12. The firm has a 50-day moving average price of $126.69 and a 200-day moving average price of $123.92.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 earnings per share. As a group, equities analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.